- Corporate Officers - N
- Nolan Sean P.
Insider Trading History of Nolan Sean P.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Nolan Sean P. since 2014.
This trader's CIK number is 1569926.
At the time of last reporting, Nolan Sean P. was the Chief Executive Officer of Taysha Gene Therapies, Inc.. (stock ticker symbol TSHA).
Also see all insider trading activities at Taysha Gene Therapies, Inc..
Note that in the past
Nolan Sean P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avexis, Inc. (AVXS) by Nolan Sean P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | AVXS | 0 | $0 | 10,000 | $1,292,080 | 10,000 | $159,400 |
Yearly summary of insider trading at Taysha Gene Therapies, Inc. (TSHA) by Nolan Sean P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | TSHA | 444,444 | $399,999 | 0 | $0 | 0 | $0 |
| 2021 | TSHA | 1,170 | $26,149 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intermune Inc (ITMN) by Nolan Sean P.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | ITMN | 0 | $0 | 57,529 | $2,582,959 | 48,000 | $436,627 |
Insider trading activities at 3 companies by Nolan Sean P.:
1. Avexis, Inc. (AVXS)
2. Taysha Gene Therapies, Inc. (TSHA)
3. Intermune Inc (ITMN)
Table 1. Insider trading of Avexis, Inc. (AVXS) by Nolan Sean P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-03-07 | AVXS | Option Ex | 10,000 | 15.94 | 159,400 |
| 2018-03-07 | AVXS | Sale | 10,000 | 129.21 | 1,292,080 |
Table 2. Insider trading of Taysha Gene Therapies, Inc. (TSHA) by Nolan Sean P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-16 | TSHA | Buy | 444,444 | .90 | 399,999 |
| 2021-05-20 | TSHA | Buy | 1,170 | 22.35 | 26,149 |
Table 3. Insider trading of Intermune Inc (ITMN) by Nolan Sean P.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-08-13 | ITMN | Option Ex | 17,000 | 9.29 | 157,930 |
| 2014-08-13 | ITMN | Sale | 17,000 | 50.00 | 850,000 |
| 2014-06-18 | ITMN | Option Ex | 10,000 | 9.29 | 92,899 |
| 2014-06-18 | ITMN | Sale | 10,000 | 47.10 | 471,000 |
| 2014-06-13 | ITMN | Option Ex | 10,000 | 9.29 | 92,899 |
| 2014-06-13 | ITMN | Sale | 10,000 | 44.35 | 443,500 |
| 2014-06-06 | ITMN | Option Ex | 10,000 | 9.29 | 92,899 |
| 2014-06-06 | ITMN | Sale | 10,000 | 41.25 | 412,500 |
| 2014-06-03 | ITMN | Sale | 385 | 38.78 | 14,930 |
| 2014-05-30 | ITMN | Option Ex | 1,000 | .00 | 0 |
| 2014-05-19 | ITMN | Sale | 7,500 | 39.50 | 296,250 |
| 2014-05-08 | ITMN | Sale | 2,644 | 35.85 | 94,779 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Nolan Sean P.
(Chief Executive Officer of Taysha Gene Therapies, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.